These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1182 related articles for article (PubMed ID: 28801166)

  • 21. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
    Bello M; Morales-González JA
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
    Lu MC; Zhang X; Wu F; Tan SJ; Zhao J; You QD; Jiang ZY
    J Med Chem; 2019 Jul; 62(14):6796-6813. PubMed ID: 31283229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).
    Zhong M; Lynch A; Muellers SN; Jehle S; Luo L; Hall DR; Iwase R; Carolan JP; Egbert M; Wakefield A; Streu K; Harvey CM; Ortet PC; Kozakov D; Vajda S; Allen KN; Whitty A
    Biochemistry; 2020 Feb; 59(4):563-581. PubMed ID: 31851823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish.
    Raghunath A; Nagarajan R; Sundarraj K; Palanisamy K; Perumal E
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):259-270. PubMed ID: 30861618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.
    Tran KT; Pallesen JS; Solbak SMØ; Narayanan D; Baig A; Zang J; Aguayo-Orozco A; Carmona RMC; Garcia AD; Bach A
    J Med Chem; 2019 Sep; 62(17):8028-8052. PubMed ID: 31411465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy.
    Yoshizaki Y; Mori T; Ishigami-Yuasa M; Kikuchi E; Takahashi D; Zeniya M; Nomura N; Mori Y; Araki Y; Ando F; Mandai S; Kasagi Y; Arai Y; Sasaki E; Yoshida S; Kagechika H; Rai T; Uchida S; Sohara E
    Sci Rep; 2017 Jun; 7(1):3945. PubMed ID: 28638054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.
    Leung CH; Zhang JT; Yang GJ; Liu H; Han QB; Ma DL
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bis-Michael Acceptors as Novel Probes to Study the Keap1/Nrf2/ARE Pathway.
    Deny LJ; Traboulsi H; Cantin AM; Marsault É; Richter MV; Bélanger G
    J Med Chem; 2016 Oct; 59(20):9431-9442. PubMed ID: 27682717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
    Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
    Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review.
    Singh E; Matada GSP; Abbas N; Dhiwar PS; Ghara A; Das A
    Inflammopharmacology; 2021 Oct; 29(5):1347-1355. PubMed ID: 34373972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis.
    Meng N; Tang H; Zhang H; Jiang C; Su L; Min X; Zhang W; Zhang H; Miao Z; Zhang W; Zhuang C
    Free Radic Biol Med; 2018 Mar; 117():228-237. PubMed ID: 29428410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses.
    Perez-Leal O; Barrero CA; Merali S
    J Biol Chem; 2017 Aug; 292(34):14108-14121. PubMed ID: 28684421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
    Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
    Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of polypodiside as a Keap1-dependent Nrf2 activator attenuating oxidative stress and accumulation of extracellular matrix in glomerular mesangial cells under high glucose.
    Yao H; Zhang N; Zhang W; Li J; Hua H; Li Y
    Bioorg Med Chem; 2020 Dec; 28(24):115833. PubMed ID: 33166928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery.
    Narayanan D; Tran KT; Pallesen JS; Solbak SMØ; Qin Y; Mukminova E; Luchini M; Vasilyeva KO; González Chichón D; Goutsiou G; Poulsen C; Haapanen N; Popowicz GM; Sattler M; Olagnier D; Gajhede M; Bach A
    J Med Chem; 2022 Nov; 65(21):14481-14526. PubMed ID: 36263945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells.
    Zhang Z; Peng L; Fu Y; Wang W; Wang P; Zhou F
    ACS Chem Neurosci; 2021 Mar; 12(5):872-882. PubMed ID: 33571414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.
    Lu MC; Yuan ZW; Jiang YL; Chen ZY; You QD; Jiang ZY
    Mol Biosyst; 2016 Apr; 12(4):1378-87. PubMed ID: 26935067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a High-Throughput Cul3-Keap1 Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for Identifying Nrf2 Activators.
    Poore DD; Hofmann G; Wolfe LA; Qi H; Jiang M; Fischer M; Wu Z; Sweitzer TD; Chakravorty S; Donovan B; Li H
    SLAS Discov; 2019 Feb; 24(2):175-189. PubMed ID: 30383469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain.
    Dong T; Liu W; Shen Z; Li L; Chen S; Lei X
    Sci Rep; 2016 Jan; 6():19231. PubMed ID: 26757824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.